Theme :
Stepping to Improvement
Endokrinology Problem in JKN Era
5 - 6 Agustus 2017
Hotel Aryaduta Bandung
Simposium Endokrinologi
Klinik Bandung Ke-XIV
Perkumpulan Endokrinologi Indonesia (PERKENI) Cabang Bandung
Simposium
Workshop
Pameran
P E R K E N I P E R K U M P U L A N ENDOKRINOLOGI I N D O N E S I A
SKP IDI
Sekretariat Panitia : PT. 40116Phone : +62 22 426 4028, 426 4015, Fax : +62 22 426 4029, Mobile/Whatsapp: +62 Email : endokrinologikl
endokrinologikl www. travelandconvex.com Traveland Convex Indonesia | Jl. Cihampelas 56 B Bandung
812 1414 3928 inikbandung @gmail .com
P E R K E N I
PERKUMPULAN ENDOKRINOLOGI I N D O N E S I A
Sehubungan dengan kewajiban mensejahterakan bangsa dan meningkatkan pengetahuan
sejawat dokter Indonesia untuk mengembangkan ilmu di bidang kedokteran, Perkeni
cabang Bandung bekerjasama dengan PT. Traveland Convex Indonesia menyelenggarakan
kegiatan Simposium Endokrinologi Klinik Bandung Ke XIV pada tanggal 5 -6 Agustus 2017
di Hotel Aryaduta Bandung.
Pengantar
Kami mengundang semua pihak yang terkait untuk berpartisipasi agar acara ini berjalan
dengan baik dan bermanfaat bagi dunia kesehatan di Indonesia.
Perkeni cabang Bandung menghadirkan para pakar yang akan berbagi ilmu dan
pengalaman untuk meningkatkan pengetahuan, serta ketajaman daya analisis untuk
menentukan sikap dalam menghadapi masalah-masalah di bidang kedokteran, khususnya
bidang Endokrinologi, sehingga dapat meningkatkan kualitas penatalaksanaan penderita
di masyarakat Indonesia.
Penyelenggara,
Perkeni cabang Bandung
dengan PT Traveland Convex Indonesia.
Simposium
Endokrinologi Klinik Bandung Ke-XIV 2017
Topics :
- Optimizing Referal System of Endocrine Problems in JKN Era -
-
New Treatment to Help Your Type 2 Diabetes Patients - Nephrodiabetic Treatment
- .
-
Is All Anti Thyroid Drug The Same
Management of Adrenal Insufficiency: The Role of IV Hydrocortisone - Risk Factors for Dementia in Patients with DM.
- Insulin Update & GLP 1 Update -
Insulin Therapy: Practical Case on Initiation and Intensification
Achieving Antihyperglycemic Treatment Goal with New Invention on Incretin Based Therapies
- Synchronizing Diabetes Treatment Approaches to Needs
- New Frontiers in the Management of Hypertension and Metabolic Disease - The New Horizon in Type-2 Diabetes Mellitus Management
Workshops:
1. Advances & Lessons Learned from the Clinicians
2. Advancing Dyslipidemia Management in Patients with T2DM 3. Optimized Glucose-Lowering Control with Modified Release Gliclazide Formulation
4. How to Monitor Your Patient's Glycemic Condition?
5. Get to Target in Diabetes : Optimizing Dose of Metformin and Importance of Achieving Target HbA1C
6. Management of Hypoglycemia in T2DM Therapy
7. New Paradigm of T2DM - from 2017 Guideline to Real Practice
Informasi Umum
Simposium Endokrinologi Klinik Bandung Ke-XIV 2017
Tema : Stepping to Improvement Endokrinology Problem in JKN Era
Bentuk Acara
? 3 Plenary Lecture
? 4 Symposium
? 2 Pre Lunch Symposium
? 2 Lunch Symposium
? 7 Workshop
Waktu & Tempat
Sabtu - Minggu, 5 – 6 Agustus 2017 Hotel Aryaduta Bandung
Jl. Sumatra No. 51 Bandung
Rekening Panitia
An. Bank No Rek.
TRAVELAND CONVEX INDONESIA BCA KCU ASIA AFRIKA
TOPIK 07.00 - 07.30 07.30 - 08.00 Re-registration Opening Ceremony PLENARY LECTURE I :
PLENARY LECTURE II : : Is All Anti Thyroid Drug The Same 08.00 - 08.30
08.00 - 08.30
10.30 - 11.00
10.00 - 11.50
SYMPOSIUM I : Insulin Update & GLP 1 Update
LUNCH SYMPOSIUM I: New Frontiers in the Management of Hypertension and Metabolic Disease
08.30 - 08.50 08.50 - 09.10 09.10 - 09.20
The role of GLP-1 in type 2 diabetes
Achieve optimal glycaemic control with insulin therapy Discussion 09.20 - 09.40 09.40 - 10.30 11.50 - 13.00 Coffee Break Lunch
PRE LUNCH SYMPOSIUM I : Achieving Antihyperglycemic Greatment Goal with New Invention on Incretin Based Therapies
09.40 - 10.00 Are all DPP4 inhibitors the same?
A closer look of linagliptin ~ The novel DPP4-inhibitor with a broad action & powerful efficacy in T2DM management
dr. Putu Moda Arsana, SpPD-KEMD.FINASIM
WAKTU
Optimizing Referal System of Endocrine Problems in JKN Era
Hyperthyroidism: how can we manage it better
Prof. Dr. Johan S Masjhur, dr.,SpPD-KEMD.SpKN Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM
Nanny NM Soetedjo, dr., SpPD-KEMD.M.Kes.DCN.FINASIM
Nanny NM Soetedjo, dr., SpPD-KEMD.M.Kes.DCN.FINASIM 11.00 - 11.20
Prof. Dr. Johan S. Masjhur, dr., SpPD-KEMD., SpKN.
Mod: Nanny NM Soetedjo, dr., SpPD-KEMD.M.Kes.DCN.FINASIM
Mod : Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM
Mod : Augusta YL Arifin, dr.,SpPD-KEMD.FINASIM
AGENDA ACARA | H-1
ENDOKRINOLOGI KLINIK BANDUNG XIV 2017
P E R K E N I P E R K U M P U L A N ENDOKRINOLOGI I N D O N E S I A Sabtu, 5 Agustus 2017 Discussion
The powerful 24 hr BP reductions with single pill combination: focus on telmisartan + amlodipine
11.40 - 11.50
11.20 - 11.40 Prof. Dr. Rully MA Roesli, dr., SpPD-KGH.FINASIM
Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM
PEMBICARA / MODERATOR
Prof. Dr. Achmad Rudijanto, dr.,SpPD-KEMD.FINASIM Mod : Prof. Dr. Achmad Rudijanto, dr., SpPD-KEMD.FINASIM Mod: Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM
Introducing sitagliptin - extended released metformin: The power to lower HbA1c
Discussion 10.00 - 10.20
10.20 - 10.30 08.30 - 09.20
TOPIK
SYMPOSIUM II : New Treatment to Help Your Type 2 Diabetes Patients
SYMPOSIUM III : Nephrodiabetic Treatment
WORKSHOP 1 : Advances & Lessons Learned from the Clinicians
WORKSHOP 2 : Advancing Dyslipidemia Management in Patients with T2DM
WORKSHOP 3 : Optimized Glucose-Lowering Control with Modified Release Gliclazide Formulation
WORKSHOP 4 : How to Monitor Your Patient's Glycemic Condition? 13.00 - 13.50 13.00 - 13.50 15.00 - 17.00 13.00 - 13.20 13.20 - 13.40 13.40 - 13.50 13.50 - 14.10
Why do we need SGLT-2 inhibitors and how do they work?
What are the key clinical data and local experience for dapagliflozin? Discussion
Early done combination approach the reason behind, focus on glimepiride + metformin
14.40 - 15.00 Coffee Break
WAKTU
- The importance of 24 hour BP control for managing CV risk
- Clinical advances in DPP4 inhibitor treatment for The management of T2DM - Management of dyslipidemia in patients :
- Prevention of CVD in T2DM patients: which is more important decrease in LDL or glucosede ?
T2DM patients still need therapy without target ?
- Role of gliclazide MR Today, an efficacy and safety you can trust
- Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON
- How to use SMBG wisely in your diabetic patients?
- When to measure HbA1c or Glycated Albumin wisely for your diabetic patients?
Rubin Surachno Gondodiputro, dr., SpPD-KGH.FINASIM Augusta YL Arifin, dr.,SpPD-KEMD.FINASIM
Nanny NM Soetedjo, dr., SpPD-KEMD.M.Kes.DCN.FINASIM Maya Kusumawati, dr.,SpPD
Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM Octo Indradjaja, dr., SpPD-KEMD.FINASIM
Miftahurachman, dr., SpPD-KEMD.M.Kes,FINASIM Hoo Yumilia, dr., SpPD-KEMD.FINASIM
PARALLEL WORKSHOP
Nanny NM Soetedjo, dr., SpPD-KEMD.M.Kes.DCN.FINASIM Mod : Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM
PEMBICARA / MODERATOR
Mod : Augusta YL Arifin, dr.,SpPD-KEMD.FINASIM Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM Octo Indradjaja, dr., SpPD-KEMD.FINASIM
Nutritional management in diabetic nefropathy: effect of ketoacid on progression in diabetic nefropathy Discussion
14.10 - 14.30 14.30 - 14.40
Rubin Surachno Gondodiputro, dr., SpPD-KGH.FINASIM
AGENDA ACARA | H-1
ENDOKRINOLOGI KLINIK BANDUNG XIV 2017
P E R K E N I
P E R K U M P U L A N ENDOKRINOLOGI I N D O N E S I A
TOPIK
08.00 - 08.30 Re-registration
09.40 - 10.00 Insulin Initiation: Premix or Long Acting insulin? Miftahurachman, dr., SpPD-KEMD.M.Kes.FINASIM
WAKTU
PRE LUNCH SYMPOSIUM II :
Synchronizing Diabetes Treatment Approaches To Needs 10.30 - 11.20
Addressing the unmet need of basal insulin therapy in diabetes patient
Prof. Dr. Johan S Masjhur, dr.,SpPD-KEMD.SpKN
Augusta YL Arifin, dr.,SpPD-KEMD, FINASIM 10.30 - 10.50
Mod : Dr. Hikmat Permana, dr.,SpPD-KEMD.FINASIM
Discussion
Overview the next generation of basal insulin in diabetes management: Translating pharmacokinetic profile into clinical practice
11.10 - 11.20
10.50 - 11.10 Nanny NM Soetedjo, dr., SpPD-KEMD.M.Kes.DCN.FINASIM Discussion
insulin Intensification:
When Simple Injection does not Control Blood Glucose 10.00 - 10.20
10.20 - 10.30
Dr. Hikmat Permana, dr.,SpPD-KEMD.FINASIM
AGENDA ACARA | H-2
ENDOKRINOLOGI KLINIK BANDUNG XIV 2017
P E R K E N I P E R K U M P U L A N ENDOKRINOLOGI I N D O N E S I A Minggu, 6 Agustus 2017 LUNCH SYMPOSIUM II :
The New Horizon In Type-2 Diabetes Mellitus Management Synergistic Effects (Saxagliptin + Metformin-XR) in Aggressive Treatment of T2DM
11.20 - 11.40 11.20 - 12.10
Discussion
Innovation of Biosimilar Basal Insulin in Type-2 Diabetes Management
12.00 - 12.10 11.40 - 12.00
Augusta YL Arifin, dr., SpPD-KEMD.FINASIM
Mod: Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM
Hoo Yumilia, dr., SpPD-KEMD.FINASIM PLENARY LECTURE III
08.30 - 09.20 08.30 - 08.55 08.55 - 09.20 09.20 - 09.40 09.40 - 10.30 Coffee Break SYMPOSIUM IV :
Insulin Therapy: Practical Case on initiation and intensification Risk Factors for Dementia in Patients with DM
Management of Adrenal Insufficiency: the Role of IV Hydrocortisone Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM
Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM
Mod: Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM Mod : Augusta YL Arifin, dr., SpPD-KEMD.FINASIM
PEMBICARA / MODERATOR
MEDICOLEGAL SESSION 08.10 - 08.30
AGENDA ACARA | H-2
ENDOKRINOLOGI KLINIK BANDUNG XIV 2017
P E R K E N I P E R K U M P U L A N ENDOKRINOLOGI I N D O N E S I A Minggu, 6 Agustus 2017 TOPIK WAKTU WORKSHOP 5 :
Get to Target in Diabetes : Optimizing Dose of Metformin and Importance of Achieving Target HbA1C
13.00 - 15.00
13.00 - 15.00
Optimizing benefit of T2DM patients with optimal dose of metformin Nanny NM Soetedjo, dr., SpPD-KEMD.M.Kes.DCN.FINASIM
PARALLEL WORKSHOP 12.10 - 13.00 Lunch
Fixed dose combination in Type-2 Diabetes Management
What we need to know? Ervita, dr.,SpPD.M.Kes
Prof. Dr. Johan S Masjhur, dr.,SpPD-KEMD.SpKN
PEMBICARA / MODERATOR
WORKSHOP 6 :
Management of Hypoglicemia in T2DM Theraphy
A Call a Call to action for hypoglycemia risk in type 2 DMT2 Therapy :
how to manage it? Hoo Yumilia, dr.,SpPD-KEMD.FINASIM
WORKSHOP 7 :
New Paradigm of T2DM - from 2017 Guideline to Real Practice Current Burden and Management updates of Type 2 Diabetes Mellitus How to implement Insulin-Independent Therapy in daily clinical practice
Octo Indradjaja, dr.,SpPD-KEMD.FINASIM Dr. Hikmat Permana, dr.,SpPD-KEMD.FINASIM The new paradigm: the role of DPP4 - Inhibitor in combination with
FORMULIR PENDAFTARAN
Nama
Alamat Kota
Check in date Check out date Qty Room
Hotel Aryaduta Bandung
Sudah termasuk sarapan pagi untuk 2 Orang
IDR 950,000 /night Superior Room Hotel
Total
Registrasi
Rp.
Rp.
Rp.
Biaya Pendaftaran dapat di transferred ke :
An. TRAVELAND CONVEX INDONESIA Bank BCA KCU ASIA AFRIKA
No Rek. 008 3434 888 Pendaftar Pendaftaran
(Simposium & Workshop)
No Registration : Telepon Fax
Mobile Phone
Rp
2,000,000,-Rp
1,250,000,-Rp
2,500,000,-Rp
1,500,000,-Sebelum 15 Juli 2017 Sesudah 15 Juli 2017 Type Kamar Sekretariat Panitia : PT. Jl. Cihampelas 56 B Bandung 40116 Phone : +62 22 426 4028, 426 4015 Fax : +62 22 426 4029 Mobile/Whatsapp: +62 81214143928 Email : endokrinologikl endokrinologiklTraveland Convex Indonesia
inikbandung @gmail .com
www. inikbdg.com
Contact Person : Eva :081214143928
